{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:45:10Z","timestamp":1791265510449,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["733176"],"award-info":[{"award-number":["733176"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0G4820N"],"award-info":[{"award-number":["G0G4820N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C24M\/19\/006"],"award-info":[{"award-number":["C24M\/19\/006"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C24\/17\/061"],"award-info":[{"award-number":["C24\/17\/061"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"CSCO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201706760059"],"award-info":[{"award-number":["201706760059"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["C3\/19\/057"],"award-info":[{"award-number":["C3\/19\/057"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ebiom.2022.104240","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T13:23:11Z","timestamp":1661606591000},"page":"104240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0912-2632","authenticated-orcid":false,"given":"Ji","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Bright","family":"Yakass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3527-1145","authenticated-orcid":false,"given":"Bert","family":"Malengier-Devlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Van Looveren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6928-0931","authenticated-orcid":false,"given":"Lorena","family":"Sanchez-Felipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vercruysse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Weynand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahadesh Prasad Arkalagud","family":"Javarappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0621-876X","authenticated-orcid":false,"given":"Osbourne","family":"Quaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Matthys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2816-1530","authenticated-orcid":false,"given":"Tania","family":"Roskams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-7514","authenticated-orcid":false,"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik Jan","family":"Thibaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8117-9166","authenticated-orcid":false,"given":"Kai","family":"Dallmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2022.104240_bib0001","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: Innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-020-0205-6","article-title":"Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection","volume":"5","author":"Staples","year":"2020","journal-title":"npj Vaccines"},{"key":"10.1016\/j.ebiom.2022.104240_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taz040","article-title":"Severe yellow fever in Brazil: Clinical characteristics and management","volume":"26","author":"Ho","year":"2019","journal-title":"J Travel Med"},{"key":"10.1016\/j.ebiom.2022.104240_bib0004","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S1473-3099(17)30419-X","article-title":"Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis","volume":"17","author":"Shearer","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2022.104240_bib0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1473-3099(16)30513-8","article-title":"Spread of yellow fever virus outbreak in angola and the democratic republic of the Congo 2015\u201316: a modelling study","volume":"17","author":"Kraemer","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2022.104240_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-19625-9","article-title":"Risk of yellow fever virus transmission in the Asia-Pacific region","volume":"11","author":"Lataillade","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2022.104240_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taab015","article-title":"Yellow fever in Asia-a risk analysis","volume":"28","author":"Cracknell Daniels","year":"2021","journal-title":"J Travel Med"},{"key":"10.1016\/j.ebiom.2022.104240_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14090891","article-title":"The present and future of yellow fever vaccines","volume":"14","author":"Hansen","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ebiom.2022.104240_bib0009","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4161\/hv.28117","article-title":"The yellow fever 17D virus as a platform for new live attenuated vaccines","volume":"10","author":"Bonaldo","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.ebiom.2022.104240_bib0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biologicals.2020.01.008","article-title":"Towards rabies elimination in the Asia-pacific region: from theory to practice","volume":"64","author":"Rupprecht","year":"2020","journal-title":"Biologicals"},{"key":"10.1016\/j.ebiom.2022.104240_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-018-0092-2","article-title":"A yellow fever\u2013Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice","volume":"3","author":"Kum","year":"2018","journal-title":"npj Vaccines"},{"key":"10.1016\/j.ebiom.2022.104240_bib0012","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.vaccine.2010.11.079","article-title":"Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs","volume":"29","author":"Jiang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2022.104240_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100295","article-title":"A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice","volume":"3","author":"Boudewijns","year":"2021","journal-title":"JHEP Reports"},{"key":"10.1016\/j.ebiom.2022.104240_bib0014","doi-asserted-by":"crossref","first-page":"02494","DOI":"10.1128\/mBio.02494-19","article-title":"A chimeric Japanese encephalitis vaccine protects against lethal yellow fever virus infection without inducing neutralizing antibodies","volume":"11","author":"Mishra","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.ebiom.2022.104240_bib0015","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/22221751.2020.1730709","article-title":"A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice","volume":"9","author":"Kum","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ebiom.2022.104240_bib0016","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/hv.2.2.2555","article-title":"Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes","volume":"2","author":"Guirakhoo","year":"2006","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.ebiom.2022.104240_bib0017","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.ebiom.2022.104240_bib0018","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41586-020-3035-9","article-title":"A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate","volume":"590","author":"Sanchez-Felipe","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104240_bib0019","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.omtm.2022.03.010","article-title":"Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate","volume":"25","author":"Li","year":"2022","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"10.1016\/j.ebiom.2022.104240_bib0020","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1080\/22221751.2021.2008772","article-title":"Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice","volume":"10","author":"Ma","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ebiom.2022.104240_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.67023","article-title":"Impact of covid-19-related disruptions to measles, meningococcal a, and yellow fever vaccination in 10 countries","volume":"10","author":"Gaythorpe","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ebiom.2022.104240_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41426-018-0053-x","article-title":"Molecular determinants of Yellow Fever Virus pathogenicity in Syrian golden hamsters: one mutation away from virulence article","volume":"7","author":"Klitting","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ebiom.2022.104240_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2012.10.031","article-title":"Simple and inexpensive three-step rapid amplification of cDNA 5\u2032 ends using 5\u2032 phosphorylated primers","volume":"434","author":"Dallmeier","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ebiom.2022.104240_bib0024","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K","article-title":"Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae","volume":"15","author":"Goldstein","year":"1999","journal-title":"Yeast"},{"key":"10.1016\/j.ebiom.2022.104240_bib0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P","article-title":"Heterologous URA3MX cassettes for gene replacement in Saccharomyces cerevisiae","volume":"15","author":"Goldstein","year":"1999","journal-title":"Yeast"},{"key":"10.1016\/j.ebiom.2022.104240_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103403","article-title":"Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters","volume":"68","author":"Abdelnabi","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2022.104240_bib0027","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41564-021-01047-y","article-title":"Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo","volume":"7","author":"Port","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0028","doi-asserted-by":"crossref","unstructured":"Sharma S, Vercruysse T, Sanchez-Felipe L, et al. Updated vaccine protects from infection with SARS-CoV-2 variants, prevents transmission and is immunogenic against Omicron in hamsters. bioRxiv. 2022; 2021.11.12.468374. [preprint]","DOI":"10.1101\/2021.11.12.468374"},{"key":"10.1016\/j.ebiom.2022.104240_bib0029","doi-asserted-by":"crossref","first-page":"e02548","DOI":"10.1128\/spectrum.02548-21","article-title":"A high-throughput yellow fever neutralization assay","volume":"10","author":"Rasulova","year":"2022","journal-title":"Microbiology Spectrum"},{"key":"10.1016\/j.ebiom.2022.104240_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-19684-y","article-title":"STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters","volume":"11","author":"Boudewijns","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2022.104240_bib0031","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0032","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1189\/jlb.0303093","article-title":"Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation","volume":"74","author":"Harvey","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0033","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.gastro.2009.03.053","article-title":"Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans","volume":"137","author":"Wasmuth","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2022.104240_bib0034","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/320199","article-title":"Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies","volume":"183","author":"Tesh","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2022.104240_bib0035","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1016\/j.vaccine.2011.06.034","article-title":"Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model","volume":"29","author":"Julander","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2022.104240_bib0036","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/v12050520","article-title":"The effects of pre-existing antibodies on live-attenuated viral vaccines","volume":"12","author":"Mok","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2022.104240_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1009673","article-title":"Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and mice","volume":"17","author":"Larocca","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2022.104240_bib0038","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.aav6618","article-title":"Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region","volume":"363","author":"Rodriguez-Barraquer","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104240_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.164","article-title":"Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity","volume":"1","author":"Chan","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-019-0133-5","article-title":"Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination","volume":"4","author":"Bradt","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.ebiom.2022.104240_bib0041","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMe2204695","article-title":"Does the World Still Need New Covid-19 Vaccines?","volume":"22","author":"Nohynek","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104240_bib0042","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.immuni.2021.06.017","article-title":"COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead","volume":"54","author":"Massinga Loemb\u00e9","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2022.104240_bib0043","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41579-020-00441-3","article-title":"Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa","volume":"18","author":"Margolin","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0044","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1002\/jmv.27027","article-title":"The spread of Yellow fever amidst the COVID-19 pandemic in Africa and the ongoing efforts to mitigate it","volume":"93","author":"\u00c7avdaro\u011flu","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0045","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13091","article-title":"Correlates of protection against SARS-CoV-2 infection and COVID-19 disease","author":"Goldblatt","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ebiom.2022.104240_bib0046","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S2213-2600(21)00220-4","article-title":"BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers","volume":"9","author":"Lustig","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ebiom.2022.104240_bib0047","first-page":"1","article-title":"Pre-existing immunity against vaccine vectors - friend or foe?","volume":"159","author":"Saxena","year":"2013","journal-title":"Microbiol (United Kingdom)"},{"key":"10.1016\/j.ebiom.2022.104240_bib0048","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1099\/vir.0.81104-0","article-title":"Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity","volume":"86","author":"Lauterbach","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0049","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104240_bib0050","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.77.11.6305-6313.2003","article-title":"Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene","volume":"77","author":"Casimiro","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0051","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1128\/JVI.79.15.9694-9701.2005","article-title":"Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (ad11) and ad35 vaccine vectors in the presence of Anti-Ad5 immunity","volume":"79","author":"Lemckert","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0052","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","article-title":"Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity","volume":"172","author":"Barouch","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0053","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1128\/JVI.00405-09","article-title":"Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo","volume":"83","author":"Pichla-Gollon","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0054","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vaccine.2010.10.037","article-title":"A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults","volume":"29","author":"Ledgerwood","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2022.104240_bib0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2022.104240_bib0056","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/S0140-6736(18)32488-7","article-title":"Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial","volume":"392","author":"Reisinger","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2022.104240_bib0057","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1874357901206010012","article-title":"Evaluation of measles vaccine virus as a vector to deliver respiratory syncytial virus fusion protein or epstein-barr virus glycoprotein gp350","volume":"6","author":"Mok","year":"2012","journal-title":"Open Virol J"},{"key":"10.1016\/j.ebiom.2022.104240_bib0058","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/JVI.78.1.146-157.2004","article-title":"A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV","volume":"78","author":"Lorin","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2022.104240_bib0059","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104240_bib0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104240_bib0061","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:34:08Z","timestamp":1778873648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422004224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":61,"alternative-id":["S2352396422004224"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104240","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104240"}}